| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.00092 | 1 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.00058 | 1 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.00049 | 1 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.00032 | 1 |